130 related articles for article (PubMed ID: 10461568)
1. Clinical and brain 18fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease.
al-Essa MA; al-Shamsan LA; Ozand PT
Eur J Paediatr Neurol; 1999; 3(3):125-7. PubMed ID: 10461568
[TBL] [Abstract][Full Text] [Related]
2. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in propionic acidemia: clinical and MRI correlations.
Al-Essa M; Bakheet S; Patay Z; Al-Shamsan L; Al-Sonbul A; Al-Watban J; Powe J; Ozand PT
Brain Dev; 1999 Jul; 21(5):312-7. PubMed ID: 10413018
[TBL] [Abstract][Full Text] [Related]
3. 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI correlations.
Al-Essa M; Bakheet S; Al-Shamsan L; Patay Z; Powe J; Ozand PT
Brain Dev; 1999 Jan; 21(1):24-9. PubMed ID: 10082249
[TBL] [Abstract][Full Text] [Related]
4. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease.
Al-Essa MA; Bakheet SM; Patay ZJ; Powe JE; Ozand PT
Brain Dev; 2000 Mar; 22(2):127-31. PubMed ID: 10722966
[TBL] [Abstract][Full Text] [Related]
5. FDG PET brain scan demonstrated glucose hypometabolism of bilateral caudate nuclei and putamina in a patient with chorea-acanthocytosis.
Cui R; You H; Niu N; Li F
Clin Nucl Med; 2015 Dec; 40(12):979-80. PubMed ID: 26359566
[TBL] [Abstract][Full Text] [Related]
6. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
7. Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations.
Al-Essa M; Bakheet S; Patay Z; Al-Watban J; Powe J; Joshi S; Ozand PT
Brain Dev; 1998 Aug; 20(5):295-301. PubMed ID: 9760998
[TBL] [Abstract][Full Text] [Related]
8. Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose.
Dubinsky RM; Greenberg M; Di Chiro G; Baker M; Hallett M
Mov Disord; 1989; 4(4):310-9. PubMed ID: 2811890
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
[TBL] [Abstract][Full Text] [Related]
10. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
11. Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study.
Tanaka M; Hirai S; Kondo S; Sun X; Nakagawa T; Tanaka S; Hayashi K; Okamoto K
Mov Disord; 1998 Jan; 13(1):100-7. PubMed ID: 9452334
[TBL] [Abstract][Full Text] [Related]
12. Ethylmalonic aciduria: an organic acidemia with CNS involvement and vasculopathy.
Ozand PT; Rashed M; Millington DS; Sakati N; Hazzaa S; Rahbeeni Z; al Odaib A; Youssef N; Mazrou A; Gascon GG
Brain Dev; 1994 Nov; 16 Suppl():12-22. PubMed ID: 7726376
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
[No Abstract] [Full Text] [Related]
14. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Rinne JO; Portin R; Ruottinen H; Nurmi E; Bergman J; Haaparanta M; Solin O
Arch Neurol; 2000 Apr; 57(4):470-5. PubMed ID: 10768619
[TBL] [Abstract][Full Text] [Related]
15. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.
Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM
J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470
[TBL] [Abstract][Full Text] [Related]
16. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
[TBL] [Abstract][Full Text] [Related]
17. Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome.
Otsuka M; Ichiya Y; Shima F; Kuwabara Y; Sasaki M; Fukumura T; Kato M; Masuda K; Goto I
J Neurol Sci; 1992 Sep; 111(2):195-9. PubMed ID: 1431986
[TBL] [Abstract][Full Text] [Related]
18. [Functional imaging for disorders of basal ganglia].
Otsuka M; Taniwaki T
Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793
[TBL] [Abstract][Full Text] [Related]
19. 123I-ioflupane SPECT findings of pantothenate kinase-associated neurodegeneration.
Kang A; Minoshima S
Clin Nucl Med; 2014 Sep; 39(9):849-51. PubMed ID: 24999676
[TBL] [Abstract][Full Text] [Related]
20. Interregional correlations of glucose metabolism between the basal ganglia and different cortical areas: an ultra-high resolution PET/MRI fusion study using 18F-FDG.
Kim JH; Son YD; Kim JM; Kim HK; Kim YB; Lee C; Oh CH
Braz J Med Biol Res; 2017 Nov; 51(1):e6724. PubMed ID: 29160415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
